<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1058">
  <stage>Registered</stage>
  <submitdate>6/02/2006</submitdate>
  <approvaldate>6/02/2006</approvaldate>
  <nctid>NCT00288834</nctid>
  <trial_identification>
    <studytitle>Outcomes of Swallowing Rehabilitation After Stroke</studytitle>
    <scientifictitle>Outcomes of Swallowing Rehabilitation After Stroke</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>NZ CMRF 01/10</secondaryid>
    <secondaryid>HSF NA 4992</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Stroke</healthcondition>
    <healthcondition>Cerebrovascular Accident</healthcondition>
    <healthcondition>Dysphagia</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Haemorrhagic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Behaviour - dysphagia rehabilitation

Behaviour: dysphagia rehabilitation


</interventions>
    <comparator />
    <control />
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The following outcomes measures will be assessed after 10. 20 and 30 therapeutic sessions:</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Severity rankings of swallowing pathophysiology based on videofluoroscopic swallowing studies Videofluoroscopic swallowing studies</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Functional outcome ratings of associated clinical parameters (respiratory, neurological status, self help, cognitive)</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of life ratings (SwalQOL) In addition, quality of life ratings (SwalQOL) will be assessed at one follow-up assessment six months post discharge.</outcome>
      <timepoint />
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Subjects will represent the diagnostic categories of single event brain stem injury,
             right cortical stroke and left cortical stroke.

          -  Chronic dysphagia at least 6 months post onset secondary to single neurological event,
             brain stem, right cortical or left cortical stroke confirmed with CT or MRI

          -  Diagnosis of chronic pharyngeal phase dysphagia based on clinical and
             videofluoroscopic evaluation completed within 3 weeks of beginning treatment.

          -  Must be at least 12 months post onset with no substantial recovery of swallowing
             function. If patients have received prior swallowing treatment, they must be at least
             three months post the termination of direct treatment.

          -  Mini Mental Status Exam score &gt;21</inclusivecriteria>
    <inclusiveminage>21</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  history of pre-existing dysphagia or neurologic disease prior to the onset of the
             current disorder.

          -  MMSE score &lt; 21</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2001</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC,WA</recruitmentstate>
    <hospital>Austin and Repatriation Medical Centre - Melbourne</hospital>
    <hospital>Fremantle Hospital - Fremantle</hospital>
    <postcode> - Melbourne</postcode>
    <postcode> - Fremantle</postcode>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Alberta</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Manitoba</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Newfoundland and Labrador</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state>Singapore</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>University of Canterbury</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of Toronto</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Tan Tock Seng Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Fremantle Hospital and Health Service</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Austin Hospital, Melbourne Australia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This project proposes to evaluate the relative effectiveness of four therapy protocols for
      pharyngeal phase swallowing impairment in the stroke population. Data derived from this study
      should contribute significantly to our understanding of the rehabilitative process in the
      neurogenic dysphagic population and will provide the foundation for the establishment of
      efficacious, cost-efficient patient services.

      1. Research Question to be addressed

        1. The utilization of SEMG biofeedback monitoring in dysphagia rehabilitation facilitates
           more rapid and complete recovery than traditional rehabilitation using the same
           swallowing exercises without exteroceptive feedback.

        2. Swallowing rehabilitation provided in an intensive rehabilitative programme (10 hrs of
           treatment in the 1st week) facilitates more rapid and complete recovery than
           traditionally scheduled swallowing rehabilitation (twice weekly).</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00288834</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Maggie-Lee Huckabee, Ph.D.</name>
      <address>University of Canterbury, Van der Veer Institute for Parkinson's and Brain Research, Christchurch New Zealand</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>